Number and distribution of melanocytic nevi in individuals with a history of childhood leukemia

Cancer
L NaldiG Masera

Abstract

An increased number of melanocytic nevi at the termination of chemotherapy has been documented in children with hematologic malignancies. The persistence of the increased number of nevi over time and the relationship with personal (e.g. phenotype) and disease related variables remain to be explored. One hundred Italian patients diagnosed as having acute lymphatic or myeloid leukemia, after 1975, were recruited and compared with a group of 100 control individuals drawn from friend of the enrolled patients. Information regarding lifetime sun exposure, phenotypic characteristics, and number of nevi was collected by experienced dermatologists. Counts of nevi were expressed both as totals and as counts per unit of body surface area ("density"). Multiple linear regression analysis was employed to control for potentially confounding factors when comparing patients and controls. The patients and controls were fairly comparable in terms of constitutional characteristics, but the patients had a significantly higher number and density of nevi > or = 2 mm or larger in diameter. In addition, patients had a greater number of large nevi ( > or = 6 mm in greatest dimension), and of nevi in unusual areas, such as the palms and soles. Difference...Continue Reading

References

Jul 1, 1979·British Journal of Cancer·P HerseyW H McCarthy
Oct 3, 1992·BMJ : British Medical Journal·E A BairdR M MacKie
Jan 1, 1991·Skin Pharmacology : the Official Journal of the Skin Pharmacology Society·M A Pathak
Jul 18, 1991·The New England Journal of Medicine·H K Koh
Sep 19, 1991·The New England Journal of Medicine·J W Streilein
Nov 7, 1991·The New England Journal of Medicine·J P NegliaG D Hammond
Mar 1, 1991·Clinical and Experimental Dermatology·J M McGregorD M MacDonald
Apr 1, 1990·The American Journal of Dermatopathology·A B Ackerman, M Magana-Garcia
Nov 3, 1990·BMJ : British Medical Journal·R M MacKie
Jan 1, 1990·Medical and Pediatric Oncology·P E de WitF H Rampen
Jul 8, 1989·BMJ : British Medical Journal·B R HughesC C Bailey
Sep 21, 1989·The New England Journal of Medicine·R P WitherspoonR Storb
Jan 1, 1989·Epidemiologic Reviews·A Green, A J Swerdlow
Oct 1, 1989·Journal of the American Academy of Dermatology·S B GruberG C Roush
Sep 1, 1987·British Journal of Cancer·M M HawkinsJ E Kingston
Jun 14, 1986·British Medical Journal·A J SwerdlowD J Hole
Oct 1, 1986·British Journal of Plastic Surgery·A L Moss, J C Briggs
Mar 15, 1985·International Journal of Cancer. Journal International Du Cancer·A GreenV Siskind
Jul 1, 1981·The Journal of Investigative Dermatology·F D Malkinson, J T Keane
Mar 1, 1995·Journal of the American Academy of Dermatology·J SladeR S Bart
Dec 3, 1994·Lancet·S L HarrisonI Wronski
Feb 15, 1994·American Journal of Epidemiology·D R English, B K Armstrong
Jan 1, 1994·Journal of the American Academy of Dermatology·J W KellyB J Tate
Jan 1, 1993·Journal of the American Academy of Dermatology·C H SmithD M MacDonald
May 1, 1993·British Journal of Cancer·A GreenK Lape
Nov 3, 1951·Journal of the American Medical Association·L GOLDMAN, D F RICHFIELD
Sep 22, 1984·British Medical Journal

❮ Previous
Next ❯

Citations

Apr 6, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Sylvie EuvrardAlain Claudy
Nov 23, 2006·Current Problems in Surgery·Cecelia E SchmalbachCarol R Bradford
Apr 28, 2007·Pediatric Dermatology·Jason C ReutterPamela A Groben
Aug 18, 2012·The Australasian Journal of Dermatology·Stephanie Jane Arnold, Jonathan Bowling
Jan 31, 2006·Journal of the American Academy of Dermatology·Stefano PiasericoAndrea Peserico
Apr 29, 2005·Journal of the American Academy of Dermatology·Justin Woodhouse, Edward V Maytin
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Paolo CarliUNKNOWN Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED)
Jul 30, 2016·Pediatric Dermatology·Alexander L FogelJoyce M C Teng
Dec 13, 2017·Oncotarget·Alejandro Martin-GorgojoEduardo Nagore
May 24, 2019·American Journal of Clinical Dermatology·Ewa A Burian, Gregor B E Jemec

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.